Factors to consider before implementing telemedicine protocols to manage neonatal jaundice
- PMID: 35413167
- PMCID: PMC9348953
- DOI: 10.3345/cep.2022.00227
Factors to consider before implementing telemedicine protocols to manage neonatal jaundice
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Telemedicine as progressive treatment approach for neonatal jaundice due to the coronavirus disease 2019 pandemic.Clin Exp Pediatr. 2022 May;65(5):269-271. doi: 10.3345/cep.2021.01235. Epub 2022 Feb 7. Clin Exp Pediatr. 2022. PMID: 35130430 Free PMC article. No abstract available.
References
-
- Hansen TWR, Wong RJ, Stevenson DK. Molecular physiology and pathophysiology of bilirubin handling by the blood, liver, intestine, and brain in the newborn. Physiol Rev. 2020;100:1291–346. - PubMed
-
- Kirk JM. Neonatal jaundice: a critical review of the role and practice of bilirubin analysis. Ann Clin Biochem. 2008;45:452–62. - PubMed
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. - PubMed
-
- Bromiker R, Goldberg A, Kaplan M. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia. J Perinatol. 2017;37:1315–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
